Definition:Schedule of exceptions
📋 Schedule of exceptions is a document attached to an insurance M&A purchase agreement that carves out specific facts, circumstances, or items from the representations and warranties made by the seller. When an insurer, MGA, or brokerage is being sold, the schedule of exceptions — also referred to as a disclosure schedule in many jurisdictions — functions as the seller's mechanism for qualifying its warranties, ensuring that known issues do not automatically trigger indemnification claims after closing. It is, in effect, the seller's map of everything the buyer needs to understand about deviations from the idealized state described in the warranties.
⚙️ The preparation of this schedule is one of the most labor-intensive steps in an insurance transaction. The seller and its advisors review each warranty in the purchase agreement and disclose exceptions with specificity. For an insurance company acquisition, this might include disclosures about pending litigation, known claims reserve deficiencies, material reinsurance contract disputes, non-compliance with solvency requirements in particular jurisdictions, or key person dependencies in the underwriting team. In practice, the schedule must strike a balance: over-disclosure can undermine the buyer's ability to bring legitimate claims, while under-disclosure leaves the seller exposed. Across major markets — the United States, United Kingdom, and Continental Europe — the legal effect of disclosures in the schedule varies, and the interaction between disclosed items and the buyer's remedies is a heavily negotiated feature of the deal documentation.
🔍 The quality and thoroughness of the schedule of exceptions carries outsized importance in insurance transactions for several reasons. Insurance businesses carry embedded, long-tail liabilities that may not appear on a balance sheet, and the schedule is often where these latent exposures first surface in a structured way. Warranty and indemnity insurers scrutinize disclosure schedules closely when underwriting buy-side W&I policies, as disclosed items are typically excluded from coverage. A poorly prepared schedule can leave both the seller unprotected from post-closing claims and the buyer unable to obtain adequate W&I coverage. In cross-border deals involving regulated insurance entities, the schedule also serves as a compliance artifact — documenting, for example, jurisdictional licensing gaps or pending regulatory approvals — that informs the buyer's post-closing integration planning.
Related concepts: